Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Jul;2(5):438–448. doi: 10.1016/j.bpsc.2016.07.002

Aberrant cerebellar connectivity in bipolar disorder with psychosis

Ann K Shinn 1,4,*, Youkyung S Roh 1, Caitlin T Ravichandran 2,3,4, Justin T Baker 1,4, Dost Öngür 1,4, Bruce M Cohen 2,4
PMCID: PMC5512437  NIHMSID: NIHMS817990  PMID: 28730183

Abstract

Background

The cerebellum, which modulates affect and cognition in addition to motor functions, may contribute substantially to the pathophysiology of mood and psychotic disorders, such as bipolar disorder. A growing literature points to cerebellar abnormalities in bipolar disorder. However, no studies have investigated the topographic representations of resting state cerebellar networks in bipolar disorder, specifically their functional connectivity to cerebral cortical networks.

Methods

Using a well-defined cerebral cortical parcellation scheme as functional connectivity seeds, we compared ten cerebellar resting state networks in 49 patients with bipolar disorder and a lifetime history of psychotic features and 55 healthy control participants matched for age, sex, and image signal-to-noise ratio.

Results

Patients with psychotic bipolar disorder showed reduced cerebro-cerebellar functional connectivity in somatomotor A, ventral attention, salience, and frontoparietal control A and B networks relative to healthy control participants. These findings were not significantly correlated with current symptoms.

Conclusions

Patients with psychotic bipolar disorder showed evidence of cerebro-cerebellar dysconnectivity in selective networks. These disease-related changes were substantial and not explained by medication exposure or substance use. Therefore, they may be mechanistically relevant to the underlying susceptibility to mood dysregulation and psychosis. Cerebellar mechanisms deserve further exploration in psychiatric conditions, and this study’s findings may have value in guiding future studies on pathophysiology and treatment of mood and psychotic disorders, in particular.

Keywords: cerebellum, bipolar disorder, psychosis, functional connectivity, networks, resting state

Introduction

The cerebellum modulates affect and cognition in addition to motor performance (14), and may play a significant role in psychiatric disorders, such as bipolar disorder (BP). Indeed, a growing body of evidence points to clinical (514), molecular (1519), neurochemical (2022), structural (2339), and functional (4044) abnormalities of the cerebellum in BP. The cerebellum is reciprocally connected to higher-level association areas in prefrontal (45) and posterior parietal (46) cortices and limbic regions in medial temporal lobe (4749), and cerebellar dysfunction may mirror or contribute to well-established dysfunctions of these higher-level association areas in BP.

Resting state fMRI (rsfMRI) examines the functional connectivity (FC) of intrinsic brain networks. This technique is particularly well-suited to studying cerebro-cerebellar connectivity because communication between the cerebral cortex and cerebellum is indirect (4), with cerebral cortical signals relayed to pons before they arrive at cerebellum, and with cerebellar outputs projecting to thalamus before reaching cerebral cortex. While the polysynaptic nature of this circuitry has limited its study using traditional retrograde tracer techniques, rsfMRI, which can detect functional relationships across distributed brain areas, reveals connectivity patterns informed by, but not necessarily confined to, direct monosynaptic connections (4). RsfMRI allows investigations of cerebro-cerebellar circuits in humans in vivo and in the absence of tasks, which can limit the participation of more severely ill patients and also constrain evaluation to specific functional networks.

Previous rsfMRI studies found resting-state abnormalities of cerebellum (5052) or cerebellar FC in BP (5357). However, in all of these studies, the cerebellum was among the regions identified as abnormal during the course of whole-brain investigations. No studies have focused specifically on cerebellar FC in BP. Importantly, though the cerebellum is a complex brain region, consisting of parallel closed-circuit modular loops, with distinct circuits specific for association cortices versus motor and somatosensory cortices (45, 5860), no studies have investigated the topographic representations of resting state cerebellar networks in BP, specifically their FC to cerebral cortical networks.

As we previously summarized (61), Yeo and colleagues analyzed rsfMRI data from 1000 healthy subjects, using a clustering strategy to parcellate cerebral cortex into intrinsic components on the basis of territories sharing similar FC profiles to other regions of cortex, and found that either 7 or 17 distinct networks provide relatively stable parcellation solutions (62). Using the same 1000 subject data set and cortical parcellation solutions as a reference, Buckner and colleagues subsequently developed a parcellation of human cerebellum, assigning every cerebellar voxel to its most strongly associated cortical network using a winner-take-all approach(63). They found that the human cerebellum possesses a roughly homotopic map of the cerebral cortex and that the majority of the cerebellar cortex is connected to cerebral association networks. These cerebellar FC maps are reliable and robust; other rsfMRI studies of cerebro-cerebellar connectivity in healthy humans, using different techniques, have provided remarkably consistent cerebellar network topography (64, 65).

In this study, we applied an approach approximating that of Buckner and colleagues (63) to psychotic BP. Using the 17-network cerebral cortical functional parcellation scheme of Yeo and colleagues (62) as the basis for our FC seeds, we systematically investigated the topographic representations of resting state networks within the cerebellum in psychotic BP. We hypothesized that psychotic BP would show a pattern of reduced FC in higher-level association networks, particularly in limbic and/or salience networks, reflecting the mood dysregulation characteristic of the BP phenotype.

Methods and Materials

Participants

We compared 49 BP patients with lifetime histories of psychosis and 55 HC participants. All participants provided written informed consent. Data for patients were drawn from an ongoing psychosis study approved by the McLean Hospital Institutional Review Board, a subset of which was previously described (66). Patients were men and women with psychotic illness, ages 18–65 years, recruited from inpatient and outpatient clinical services at McLean Hospital. Exclusion criteria included any current medical or neurological illness, pregnancy, electroconvulsive treatment in the previous 3 months, history of head trauma with a significant loss of consciousness, and contraindications to magnetic resonance imaging. Within this patient database, we initially identified 71 BP with psychosis history. Of these, we excluded 22 for quality control reasons: (a) 20 for low (<100) rsfMRI signal-to-noise ratio (SNR = mean/standard deviation of the mean slice intensity time series), and (b) 16 for rsfMRI data containing > 20 outlier volumes, calculated using the SPM-based Artifact Detection Tools (ART; www.nitrc.org/projects/artifact_detect), with z-threshold set to 3, movement threshold 0.5, and rotation threshold 0.05. Fourteen of the 22 excluded patients had both low SNR and high number of motion outliers. We evaluated whether there were any significant differences in clinical and demographic factors between the 22 excluded and 49 included BP patients.

HC were selected from an existing database of 2292 adults, aged 18–83 years, scanned previously using identical pulse sequences on an identical scanner, and selected to match patients on age, sex, handedness, and image SNR. HC were also screened for motion outliers, as detected by ART. For the final 49 BP and 55 HC included in the analysis, there were no statistically significant between-group differences in mean motion (in millimeters: BP 0.25 ± 0.14, HC 0.26 ± 0.15; p = 0.93).

The Structured Clinical Interview for the DSM-IV-TR (SCID) was used for diagnosis (67). Patients were assessed for symptoms within 24 hours of scanning using the Young Mania Rating Scale (YMRS) (68), the Montgomery-Asberg Depression Rating Scale (MADRS) (69), and the Positive and Negative Syndrome Scale (PANSS) (70). We calculated total medication load (TML) (71)– a composite score of all psychotropic medications a patient was on at the time of scanning– in addition to chlorpromazine equivalent doses, because many patients were on multiple medications, including antidepressants and mood stabilizers in addition to antipsychotics. All but two patients were taking at least one antipsychotic, and 42 of the 49 patients were taking lithium or other mood stabilizer.

Image Acquisition

Imaging was performed on a Siemens 3-Tesla Tim-Trio scanner with a 12-channel phased-array head coil. Functional data were acquired using gradient-echo echoplanar imaging sensitive to blood oxygenation level–dependent (BOLD) contrast. Participants were instructed to remain still, stay awake, and keep their eyes open. No fixation image was used, but patients were monitored via eye tracking video to ensure that eyes remained open during functional scans.

The echoplanar imaging parameters were repetition time, 3000 milliseconds; echo time, 30 milliseconds; flip angle, 85°; 3mm3 voxels; field of view, 216; and 47 axial sections interleaved with no gap. Functional runs lasted 6.2 minutes (124 time points). Whole-brain coverage was achieved with sections aligned to the anterior commissure–posterior commissure plane using an automated alignment procedure, ensuring consistency among participants. Structural data included high-resolution, multiecho, magnetization-prepared, gradient-echo (ME-MPRAGE) T1-weighted images allowing increased contrast through weighted averaging of four derived images.

Image Analysis

We used the FMRIB Software Library (FSL v5.0.6) (72) for image analysis, following methods previously published (61). We discarded the first four volumes of the resting BOLD image to account for magnet stabilization. Images were slice-time and motion corrected (73), smoothed with a 6 mm Gaussian kernel, and affine registered to Montreal Neurological Institute (MNI) space. Images were low-pass filtered at 0.08 Hz (sigma = 2.09 volumes) to reduce high-frequency noise from cardiac and respiratory sources, and high-pass filtered at 0.009 Hz (sigma = 18.5 volumes) to remove low-frequency scanner drift.

We identified 10 of 17 networks in the cortical parcellation map of Yeo et al, 2011 (62) containing >30 voxels in the corresponding cerebellar network parcellations of Buckner et al., 2011 (63) (Figure 1). We created a FC seed for each of these 10 networks by segmenting the 17-network image into 17 separate maps, combining networks 9 (temporal pole) and 10 (orbitofrontal cortex) into a single limbic network to maintain consistency with the naming scheme in Baker et al., 2014 (66), and eroding each network map by one voxel layer using a 3D kernel to avoid potential boundary contamination between networks.

Figure 1. The cerebral cortex network seeds and their cerebellar representations.

Figure 1

The figures of the left and right 17-network parcellation of the human cerebral cortex are adapted with permission from Yeo et al., 2011 (62), page 1139, figure 13. The network names and the cerebral cortical regions that compose the 17 networks are from the supplementary video in Baker et al., 2013 (66). The number of voxels in each of the eroded cerebral cortical seeds was determined after the 17-network cortical parcellation (publicly available at http://www.freesurfer.net/fswiki/CorticalParcellation_Yeo2011) was resampled from 1mm to 2mm space, segmented into individual network maps, and eroded (see methods). The number of voxels within each of the Buckner et al., 2011 cerebellar network maps (63) was determined after the 17-network loose estimate of the cerebellum (publicly available at http://www.freesurfer.net/fswiki/CerebellumParcellation_Buckner2011) was resampled from 1mm to 2mm MNI space and segmented into individual network maps. This figure was originally published in Shinn et al., 2015 (61).

For each participant, the mean BOLD time course was extracted for each of the 10 networks and entered into a general linear model (GLM) using FEAT (www.fmrib.ox.ac.uk/fsl/feat5). Sources of non-neuronal variance were removed by regressing out the six rigid-body motion correction parameters and signal from white matter, ventricles, and whole brain.

Data from first-level analysis were entered into a mixed-effects group analysis using the Bayesian estimation techniques in FLAME (74). As motion can lead to systematic biases in FC, even after regressing motion estimates at the subject level, we entered mean motion (mean absolute displacement of each brain volume compared to the previous volume) (73) as a covariate in between-group analyses (75). We generated group maps for BP and HC, and performed between-group contrasts for BP > HC and HC > BP. Given our goal to investigate between-group connectivity differences in the cerebellum, we restricted our analysis to the cerebellum using the Cerebellar Atlas in FSL as a mask. We used a stringent p < 0.0005 voxel threshold, corrected for multiple comparisons using a p < 0.0025 cluster threshold. These significance criteria reflect Bonferroni adjustment of both voxel and cluster thresholds by a factor of 20 (i.e., voxel p < 0.01/20, cluster p < 0.05/20) to account for conducting two one-sided tests (i.e., BP > HC, HC > BP) in 10 different networks.

To quantitatively assess overlap between the group cerebellar maps (BP, HC) and canonical cerebellar maps (63), we calculated accuracy:

Accuracy=(True positive voxels+true negative voxels)(Positive voxels+negative voxels)

We identified positive voxels as those within the canonical cerebellar map (63). True positive voxels were those that intersected between the group map. Negative voxels were those voxels within cerebellum, but outside the canonical cerebellar map. True negative voxels were calculated as the negative voxels minus false positive voxels, or those voxels in the group cerebellar map falling outside the canonical cerebellar map. We also calculated sensitivity (true positive voxels/positive voxels) and specificity (true negative voxels/negative voxels). See Supplementary Tables S2A–C.

All BP patients were taking psychotropic medications at the time of scanning, and substance use was not a patient exclusion criterion. To examine whether effects of medications, alcohol, and/or cannabis use could be driving between-group differences, we performed post-hoc analyses of only the 49 BP patients, including TML, lifetime alcohol dependence, and lifetime cannabis dependence along with mean motion as covariates in the model. For each network in which we found significant between-group differences, we used the image of the HC > BP finding as a mask, and calculated the percent of voxels in the HC > BP map not overlapping with the map showing the main effect of each potentially confounding variable in the BP-only analysis. Since the between-group findings were significant only for BP hypoconnectivity (i.e., HC > BP), we looked at the -1 effect of TML, lifetime alcohol dependence, and lifetime cannabis dependence. To more fully examine effects of these potentially confounding variables with minimal risk of Type II error, we used a liberal significance threshold of p < 0.05, uncorrected.

Correlation with Symptoms

For BP patients, we extracted, at the single subject level, the BOLD time course of the clusters we found to be significantly different between BP and HC. For networks with more than one significant cluster (i.e., N8, N12), we obtained an average of the clusters combined. We correlated the averaged time course for the network cluster with that of the corresponding cortical network seed to obtain a quantitative measure of FC for each patient. These Pearson’s R-values were z-transformed, and then correlated with the YMRS, MADRS, and PANSS (total score, as well as the positive, negative, and general subscores) for a matrix of six symptom scales and five network contrasts. We used a significance threshold of p < 0.0016 (p < 0.05 Bonferroni-corrected for 30 tests).

In exploratory analyses, we also examined correlations between the FC finding for the somatomotor B network (N4) and YMRS item 2 (“increased motor activity/energy”); the FC finding for the ventral attention network (N7) and YMRS item 7 (“language/thought disorder,” which includes distractibility); and the FC finding for N7 with PANSS item G11 (“poor attention”).

Results

Participant Characteristics

Tables 1 and 2 provide clinical and demographic information. The psychotic BP and HC groups were comparable with respect to age and sex.

Table 1.

Participant characteristics

BP HC Statistic Significance
Sample size (N=104) 49 55
Age, mean ± SD (range), y 31 ± 12 (18–62) 30 ± 11 (18–56) t = 0.4993 p = 0.619
Female sex, no. (%) 15 (31) 17 (31) X2 = 0.001 p = 0.974

Table 2.

Additional characteristics of BP patients.

BP
Illness duration, mean ± SD (range), ya 9 ± 10 (0–42)
Inpatient hospitalized, no. (%) 33 (67)
YMRS, mean ± SD 20.2 ± 11.8
MADRS, mean ± SD 15.6 ± 10.0
PANSS, mean ± SD 55.7 ± 13.7
 PANSS positive, mean ± SD 18.7 ± 7.4
 PANSS negative, mean ± SD 9.4 ± 2.8
 PANSS general, mean ± SD 28.6 ± 7.2
Chlorpromazine Equivalent 364 ± 301 mg
Antipsychotic-free, no. (%) 2 (4)
Typical Antipsychotic, no. (%)b 3 (6)
Atypical Antipsychotic, no. (%)
 Aripiprazole 6 (12)
 Clozapine 3 (6)
 Lurasidone 3 (6)
 Olanzapine 11 (22)
 Quetiapine 12 (24)
 Risperidone 15 (31)
 Ziprasidone 3 (6)
Mood stabilizer, no. (%) 42 (86)
 Lithium 30 (61)
 Lamotrigine 12 (24)
 Valproate 6 (12)
 Oxcarbazepine 5 (10)
 Gabapentin 3 (6)
Antidepressant, no. (%) 5 (10)
Sedative-hypnotic, no. (%) 14 (29)
a

Data missing for 3 patients

b

chlorpromazine: n = 2; perphenazine n = 1.

The 22 excluded patients were comparable to the final group of 49 BP patients with respect to age, sex, duration of illness, medication exposure, and measures of depression and mania (Supplementary Table S1). Since SNR and motion outliers served as bases for exclusion, excluded patients had significantly lower SNR and higher number of motion outliers compared to the final group of BP patients. The group of excluded patients also had greater psychosis severity [as measured by higher PANSS total (Supplementary Figure S1), negative, and general psychopathology scores] and a higher proportion of inpatients at the time of scanning (Supplementary Table S1). Neither of these differences is surprising, as more acutely ill patients are less likely to tolerate the scan environment and more likely to have head motion during scanning.

Within-Group Maps

The HC group maps captured the canonical cerebellar maps of Buckner and colleagues (63) with 76.9% mean accuracy (range 63.8–89.5%) (Figure 2 and Supplementary Table S2A). Thus, we have a high degree of confidence that the methods detected regions in cerebellum that are functionally coherent with their originating cerebral cortical seeds. Mean specificity was 77.1% (range 63.5–89.6%), and mean sensitivity 64.0% (range 14.7–93.8%). Sensitivity in the dorsal attention network was particularly low (14.7%), and results relating to this network should be interpreted with caution.

Figure 2. The within-group maps capture the canonical cerebellar maps with 64–97% accuracy.

Figure 2

The canonical cerebellar maps (depicted in the uppermost rows) are from Buckner et al., 2011 (63), in which data from 1,000 healthy individuals were used to map every voxel within the cerebellum to its most strongly associated cerebral cortical network (62) using a winner-take-all approach. The percentage to the right of each healthy control (HC) or bipolar disorder (BP) group map is the estimation of the map’s spatial accuracy (=true positive voxels + true negative voxels)/(positive voxels + negative voxels), using the canonical (63) map as the reference. The HC and BP group maps were liberally thresholded at a significance level of p < 0.05, uncorrected. The boxes around each of the networks are highlighted to match the color coding of the networks in Figure 1.

The BP group maps captured the canonical cerebellar maps with 88.4% mean accuracy (range 80.7–96.7%) (Figure 2 and Supplementary Table S2B). Mean specificity was 89.1% (range 80.7–96.9%). Mean sensitivity was 47.5% (range 12.6–87.5%).

Between-Group Contrasts

Healthy Control > Psychotic BP

As shown in Figure 3 and Table 3, psychotic BP had reduced cerebro-cerebellar FC in somatomotor B (N4), ventral attention (N7), salience (N8), control A (N12), and control B (N13) networks. Cerebellar regions of greatest difference between BP and HC were in left Crus I for the somatomotor B network, right Crus I in the ventral attention network, left lobule IX and left Crus II in the salience network, right Crus I and left lobule X in the control A network, and right lobule X in the control B network.

Figure 3. Decreased cerebro-cerebellar functional connectivity in somatomotor and higher-level association networks in psychotic bipolar disorder.

Figure 3

Regions in the posterior lobe of the cerebellum, especially Crus I/II, are preferentially affected in the somatomotor B, ventral attention, salience, and control A networks. Images were generated using a p<0.0005 voxel threshold, corrected for multiple comparisons using a p<0.0025 cluster threshold. The boxes associated with each network finding are highlighted to match the color coding of the networks in Figure 1.

TABLE 3.

Differences between bipolar disorder with psychosis and healthy controls in cerebro-cerebellar network connectivity.

Group Contrast Network Cerebral cortex network seed Cluster size (voxels) Hemisphere Anatomical region in cerebellum Z-values(†Z-max forentire cluster Coordinates of local maxima
X(mm) Y(mm) Z(mm)
HC > BP N4 Somatomotor B 336 L Crus I †4.28 −26 −74 −26
Crus II 3.95 −24 −70 −38
VI 3.48 −14 −74 −24
N7 Ventral Attention 212 R Crus I †4.43 28 −80 −24
N8 Salience 445 L IX †5.15 −12 −48 −44
R X 4.39 18 −40 −46
IX 4.31 8 −50 −42
150 L Crus II †4.15 −6 −84 −32
Crus I 3.89 −12 −76 −28
N12 Control A 172 R Crus I †4.34 30 −64 −34
VI 4.29 34 −60 −28
144 L White matter
†4.21

−18

−38
−40
X 3.84 −14 −42 −44
IX 3.71 −10 −54 −38
N13 Control B 163 R X †5.57 14 −38 −44

Controlling for mean absolute displacement.

Post-hoc analyses showed that medications (i.e., TML) may have contributed to the findings in N8 and N12 but could not explain 97% of the between-group differences in N8 and 92% in N12. Lifetime alcohol dependence may have contributed to the between-group findings in all five significantly different networks, but could not explain 93% of the between-group differences in N8, 86% in N13, 75% in N12, 72% in N4, and 71% in N7. There appeared to be no effect of lifetime cannabis dependence on any between-group findings.

Psychotic BP > Healthy Control

We found no networks in which psychotic BP had increased cerebro-cerebellar FC relative to HC.

Correlation with Symptoms

We found no statistically significant correlations between FC of any of the five networks for which we found significant between-group differences and clinical scale scores (Supplementary Table S3A). We also found no correlation between somatomotor B FC and the YMRS item “increased motor activity/energy,” and no correlations between ventral attention FC with either the YMRS item “language/thought disorder” or the PANSS general item “poor attention” (Supplementary Table S3B).

Discussion

Using ten well-defined cerebral cortical networks as functional connectivity (FC) seeds, we investigated abnormalities of cerebro-cerebellar circuitry in psychotic BP, and found evidence of alterations in selective networks. Specifically, we found reduced cerebro-cerebellar FC in somatomotor B, ventral attention, salience, control A, and control B networks in psychotic BP relative to HC. Of interest, no networks showed increased cerebro-cerebellar FC in psychotic BP compared to HC.

Disrupted cerebro-cerebellar FC in ventral attention, salience, and frontoparietal control networks are consistent with abnormalities in cognitive processing in psychotic BP. The ventral attention network, with nodes in parietal operculum, medial parietal, medial frontal, precentral ventral frontal, precentral frontal, insula, and temporal brain areas (66), detects salient or behaviorally relevant stimuli in the environment that are outside the current focus of attention (76). The ventral attention network interacts dynamically with the dorsal attention network, which, in contrast, enables the selection of stimuli based on internal goals or expectations (76). Focusing attention produces sustained activation of the dorsal attention network and sustained deactivation of the ventral attention network, while reorienting attention to an unexpected but salient event produces transient activation of both dorsal and ventral attention networks (76). BP is characterized by deficits in sustained attention (77, 78), and these deficits are present during remission (79), as well as during acute mania (80, 81). Cerebro-cerebellar hypoconnectivity in the ventral attention network may reflect reduced cerebellar integration and modulation of cognitive functions required for sustained attention.

The salience network in the 17-network parcellation scheme of Yeo and colleagues (62)–consisting of cingulate sulcus, ventral prefrontal cortex (PFC)/anterior insula, lateral PFC, medial posterior PFC, and a lateral parietal area– is distributed adjacent to the brain areas of the ventral attention network, and carries out closely related functions. The salience network detects potentially important stimuli, and by integrating external stimuli with homeostatic signals from the body, it marks objects for further processing by the brain’s attentional and working memory systems (82, 83). The salience network is proposed to facilitate access to these attentional and working memory systems by dynamically switching from engagement of the internally oriented default mode network (DMN) to the task-oriented central executive (i.e., frontoparietal control) network (82). Psychosis is believed to reflect a state of aberrant salience (84), in part, and structural abnormalities in the salience network have been linked to reality distortion in the form of hallucinations (85, 86) and delusions (85). A previous study reported reduced FC between cerebellar and salience networks in schizophrenia, but not in BP (56); however, the BP sample consisted of clinically stable outpatients, and it is unclear what proportion of those BP patients had histories of psychosis. Our observation of reduced cerebro-cerebellar salience network FC in psychotic BP patients could possibly reflect misattribution of salience to otherwise irrelevant external and/or internal stimuli due to a dysfunctional switching mechanism. We did not examine dynamic interactions between networks, but this could be investigated in future studies.

The frontoparietal control network was also disrupted in psychotic BP. This network consists of portions of dorsolateral prefrontal, dorsomedial prefrontal, cingulate, orbitofrontal, precuneus, inferior parietal, and temporal cortical brain areas. Not unlike the dynamic models featuring the ventral attention and salience networks described above, a model proposes that the frontoparietal network flexibly modulates DMN and dorsal attention networks, and depending on the network to which it is coupled, the frontoparietal network dynamically facilitates both internally and externally oriented goal-directed planning (87). Accordingly, dysfunction in the frontoparietal network leads to aberrant mediation between internal and external cognitive processes, as occurs in psychotic disorders, in which individuals misattribute control of their own thoughts to external sources, misinterpret behaviors and intents of others, and experience false perceptions. Our group previously found the frontoparietal control network to be disrupted, with extensive network hypoconnectivity, in patients with psychosis (66). Dysconnectivity within cerebral cortical regions of the frontoparietal control network in psychosis appears to be mirrored within cerebellum not only in SZ, as we previously reported (61), but also, as seen here, in BP with psychotic features.

Finally, our finding of reduced somatomotor FC suggests that dysfunction in psychotic BP is not isolated to higher-order cognitive domains; it also extends to networks lower in the processing hierarchy. Though neurological soft signs are most frequently associated with schizophrenia, NSS are also common in BP (88, 89). We do not have behavioral data about NSS in our sample to determine whether our observation of abnormal somatomotor cerebro-cerebellar FC is associated with NSS, and this may be a valuable subject for future studies.

The cerebellum has a modular, lattice-like organization consisting of repeating cerebro-ponto-cerebello-thalamo-cerebral loops (60). While multiple different cerebral cortical networks are topographically represented within cerebellum, the highly stereotyped circuit arrays that make up the architecture of cerebellar cortex suggests that cerebellum may perform common computational functions for diverse tasks (60, 90). The cerebellum has been proposed to act as a forward controller, using corollary discharges to predict sensory consequences of motor and other commands (60). According to Schmahmann, the cerebellum “regulates the rate, force, rhythm, and accuracy of movements” and also of other mental processes, and lesions to cerebellum cause problems of timing and adjustment (91). Similarly, Andreasen’s “cognitive dysmetria” model (92, 93) proposes that the myriad symptoms of schizophrenia result from a unitary pathophysiology, namely incoordination of mental activity, due in part to misconnections in cerebro-cerebellar circuitry. Thus, cerebro-cerebellar hypoconnectivity in specific brain networks may underlie abnormal timing, integration, coordination, and signal processing observed as the cognitive, emotional, and behavioral symptoms of BP and other mood and psychotic disorders.

BP, especially psychotic BP, has many clinical (94, 95), genetic (96101), and neuroimaging features (102104) in common with schizophrenia such that these disorders appear to be overlapping syndromes rather than biologically discrete diseases (105). Using analogous methods, our group previously showed schizophrenia to have aberrant cerebro-cerebellar FC in many of the same networks found in the current study to be disrupted in psychotic BP, i.e., somatomotor, ventral attention, salience, and control networks (61). Schizophrenia was also characterized by DMN abnormalities, which we did not observe here in psychotic BP. The current study differed from our schizophrenia study with respect to both participant recruitment and imaging parameters; thus firm conclusions about cerebellar FC similarities and differences in these two disorders cannot be drawn from these two studies. We plan to pursue head-to-head comparisons in future studies.

The findings from this study should be considered in light of several limitations. First, data were not acquired for the purposes of this analysis, and though the patients were well-characterized with regard to depression, mania, and psychosis, they lacked measures of cognitive and motor (e.g., NSS) functioning. Second, alcohol (106) and cannabis (107109) can have detrimental effects on cerebellum, and substance use was not an exclusion criterion for patients. However, we assessed the potential contribution of alcohol and cannabis dependence by examining their effects on cerebro-cerebellar FC among BP patients, and found that while FC differences associated with alcohol dependence may have contributed to diagnostic differences, these differences cannot explain the totality of our findings. Third, though we assessed potential contributions of medication effects using a composite score accounting for all current psychotropic medications, patients were on many different treatment regimens, with different mechanisms of action, and we cannot confidently separate disease-related and medication-related effects. Fourth, by excluding patients with lower quality image data, we necessarily excluded more severely symptomatic patients, almost all of whom were inpatients at the time of scanning. This reflects the challenges of acquiring high quality data in acutely ill BP psychosis patients, and may limit the ability to generalize our findings to sicker patients. Notably, however, though PANSS scores for the excluded and included groups were statistically significantly different, the overall effect size was modest, as the total PANSS score in both the final and excluded BP groups were in the mild range for schizophrenia (110). Fifth, we focused our analyses on BP and HC group differences in cerebro-cerebellar FC. However, large-scale FC networks appear to interact with one another in dynamic ways, and future studies should investigate between-network relationships within cerebellum.

In spite of limitations, the findings from the current study may have value in guiding future studies on pathophysiology and treatment of BP and related disorders. The discovery of specific functional abnormalities in cerebellum suggests that the cerebellum might be a target for treatment intervention. Standard medications may already affect cerebellar activity, but currently employed electromagnetic therapies, such as ECT and transcranial magnetic stimulation (TMS), as well as still experimental direct and alternating current stimulations, TDCS and TACS, have all been applied to cerebrum, but rarely to cerebellum. No single cause or mechanism explains psychosis, but cerebellar mechanisms deserve further characterization in patients with mood and psychotic disorders.

Supplementary Material

supplement

Acknowledgments

We thank the patients who participated in this research, and the staff at the McLean Hospital Brain Imaging Center who provided technical assistance in acquiring the data. This research was supported by the John A. Kaneb Young Investigator Award and NIH 1K23MH100611 to AKS; NIH K23MH104515 to JTB; NIH K24MH104449 to DO; and the McLean Hospital Program for Neuropsychiatric Research (BMC).

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Financial Disclosures

Dr. Öngür reports having received research support from Roche Genentech in 2014. All other authors report no biomedical financial interests or potential conflicts of interest.

References

  • 1.Strick PL, Dum RP, Fiez JA. Cerebellum and nonmotor function. Annu Rev Neurosci. 2009;32:413–434. doi: 10.1146/annurev.neuro.31.060407.125606. [DOI] [PubMed] [Google Scholar]
  • 2.Stoodley CJ, Schmahmann JD. Functional topography in the human cerebellum: a meta-analysis of neuroimaging studies. Neuroimage. 2009;44:489–501. doi: 10.1016/j.neuroimage.2008.08.039. [DOI] [PubMed] [Google Scholar]
  • 3.Bostan AC, Dum RP, Strick PL. Cerebellar networks with the cerebral cortex and basal ganglia. Trends Cogn Sci. 2013;17:241–254. doi: 10.1016/j.tics.2013.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Buckner RL. The cerebellum and cognitive function: 25 years of insight from anatomy and neuroimaging. Neuron. 2013;80:807–815. doi: 10.1016/j.neuron.2013.10.044. [DOI] [PubMed] [Google Scholar]
  • 5.Cutting JC. Chronic mania in childhood: case report of a possible association with a radiological picture of cerebellar disease. Psychol Med. 1976;6:635–642. doi: 10.1017/s0033291700018286. [DOI] [PubMed] [Google Scholar]
  • 6.Hamilton NG, Frick RB, Takahashi T, Hopping MW. Psychiatric symptoms and cerebellar pathology. Am J Psychiatry. 1983;140:1322–1326. doi: 10.1176/ajp.140.10.1322. [DOI] [PubMed] [Google Scholar]
  • 7.Yadalam KG, Jain AK, Simpson GM. Mania in two sisters with similar cerebellar disturbance. Am J Psychiatry. 1985;142:1067–1069. doi: 10.1176/ajp.142.9.1067. [DOI] [PubMed] [Google Scholar]
  • 8.Endo M. Pituitary function, affective disorder, and cerebellar vermis atrophy. Biol Psychiatry. 1986;21:705–707. doi: 10.1016/0006-3223(86)90138-1. [DOI] [PubMed] [Google Scholar]
  • 9.Lauterbach EC. Bipolar disorders, dystonia, and compulsion after dysfunction of the cerebellum, dentatorubrothalamic tract, and substantia nigra. Biol Psychiatry. 1996;40:726–730. doi: 10.1016/0006-3223(96)82516-9. [DOI] [PubMed] [Google Scholar]
  • 10.Schmahmann JD, Sherman JC. Cerebellar cognitive affective syndrome. Int Rev Neurobiol. 1997;41:433–440. doi: 10.1016/s0074-7742(08)60363-3. [DOI] [PubMed] [Google Scholar]
  • 11.Lauterbach EC, Harris JB, Bina WF., 3rd Mood and neurobehavioral correlates of cerebellar lesions. Cognitive and behavioral neurology: official journal of the Society for Behavioral and Cognitive Neurology. 2010;23:63–73. doi: 10.1097/WNN.0b013e3181cfb541. [DOI] [PubMed] [Google Scholar]
  • 12.Can SS, Karakas Ugurlu G, Cakmak S. Dandy walker variant and bipolar I disorder with graphomania. Psychiatry investigation. 2014;11:336–339. doi: 10.4306/pi.2014.11.3.336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Das P, Chopra A, Rai A, Kuppuswamy PS. Late-onset recurrent mania as a manifestation of Wallenberg syndrome: a case report and review of the literature. Bipolar Disord. 2015;17:677–682. doi: 10.1111/bdi.12318. [DOI] [PubMed] [Google Scholar]
  • 14.Delle Chiaie R, Minichino A, Salviati M, Fiorentini S, Tonini A, Bersani FS, et al. Bipolar Spectrum Disorders in Patients With Cerebellar Lesions: A Comparison With Parkinson’s Disease. J Nerv Ment Dis. 2015;203:725–729. doi: 10.1097/NMD.0000000000000359. [DOI] [PubMed] [Google Scholar]
  • 15.Fatemi SH, Stary JM, Earle JA, Araghi-Niknam M, Eagan E. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum. Schizophr Res. 2005;72:109–122. doi: 10.1016/j.schres.2004.02.017. [DOI] [PubMed] [Google Scholar]
  • 16.Fatemi SH, Folsom TD, Thuras PD. Deficits in GABA(B) receptor system in schizophrenia and mood disorders: a postmortem study. Schizophr Res. 2011;128:37–43. doi: 10.1016/j.schres.2010.12.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Fatemi SH, Folsom TD, Rooney RJ, Thuras PD. Expression of GABAA alpha2-, beta1- and epsilon-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder. Translational psychiatry. 2013;3:e303. doi: 10.1038/tp.2013.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Fatemi SH, Folsom TD. GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism. Schizophr Res. 2015;167:42–56. doi: 10.1016/j.schres.2014.10.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Soontornniyomkij B, Everall IP, Chana G, Tsuang MT, Achim CL, Soontornniyomkij V. Tyrosine kinase B protein expression is reduced in the cerebellum of patients with bipolar disorder. J Affect Disord. 2011;133:646–654. doi: 10.1016/j.jad.2011.04.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Cecil KM, DelBello MP, Sellars MC, Strakowski SM. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders. Journal of child and adolescent psychopharmacology. 2003;13:545–555. doi: 10.1089/104454603322724931. [DOI] [PubMed] [Google Scholar]
  • 21.Singh MK, Spielman D, Libby A, Adams E, Acquaye T, Howe M, et al. Neurochemical deficits in the cerebellar vermis in child offspring of parents with bipolar disorder. Bipolar Disord. 2011;13:189–197. doi: 10.1111/j.1399-5618.2011.00902.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Johnson CP, Follmer RL, Oguz I, Warren LA, Christensen GE, Fiedorowicz JG, et al. Brain abnormalities in bipolar disorder detected by quantitative T1rho mapping. Mol Psychiatry. 2015;20:201–206. doi: 10.1038/mp.2014.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Nasrallah HA, Jacoby CG, McCalley-Whitters M. Cerebellar atrophy in schizophrenia and mania. Lancet. 1981;1:1102. doi: 10.1016/s0140-6736(81)92266-2. [DOI] [PubMed] [Google Scholar]
  • 24.Nasrallah HA, McCalley-Whitters M, Jacoby CG. Cortical atrophy in schizophrenia and mania: a comparative CT study. J Clin Psychiatry. 1982;43:439–441. [PubMed] [Google Scholar]
  • 25.Lippmann S, Manshadi M, Baldwin H, Drasin G, Rice J, Alrajeh S. Cerebellar vermis dimensions on computerized tomographic scans of schizophrenic and bipolar patients. Am J Psychiatry. 1982;139:667–668. doi: 10.1176/ajp.139.5.667. [DOI] [PubMed] [Google Scholar]
  • 26.DelBello MP, Strakowski SM, Zimmerman ME, Hawkins JM, Sax KW. MRI analysis of the cerebellum in bipolar disorder: a pilot study. Neuropsychopharmacology. 1999;21:63–68. doi: 10.1016/S0893-133X(99)00026-3. [DOI] [PubMed] [Google Scholar]
  • 27.Stoll AL, Renshaw PF, Yurgelun-Todd DA, Cohen BM. Neuroimaging in bipolar disorder: what have we learned? Biol Psychiatry. 2000;48:505–517. doi: 10.1016/s0006-3223(00)00982-3. [DOI] [PubMed] [Google Scholar]
  • 28.Mills NP, Delbello MP, Adler CM, Strakowski SM. MRI analysis of cerebellar vermal abnormalities in bipolar disorder. Am J Psychiatry. 2005;162:1530–1532. doi: 10.1176/appi.ajp.162.8.1530. [DOI] [PubMed] [Google Scholar]
  • 29.Adler CM, DelBello MP, Jarvis K, Levine A, Adams J, Strakowski SM. Voxel-based study of structural changes in first-episode patients with bipolar disorder. Biol Psychiatry. 2007;61:776–781. doi: 10.1016/j.biopsych.2006.05.042. [DOI] [PubMed] [Google Scholar]
  • 30.Moorhead TW, McKirdy J, Sussmann JE, Hall J, Lawrie SM, Johnstone EC, McIntosh AM. Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry. 2007;62:894–900. doi: 10.1016/j.biopsych.2007.03.005. [DOI] [PubMed] [Google Scholar]
  • 31.Monkul ES, Hatch JP, Sassi RB, Axelson D, Brambilla P, Nicoletti MA, et al. MRI study of the cerebellum in young bipolar patients. Progress in neuro-psychopharmacology & biological psychiatry. 2008;32:613–619. doi: 10.1016/j.pnpbp.2007.09.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Womer FY, Wang F, Chepenik LG, Kalmar JH, Spencer L, Edmiston E, et al. Sexually dimorphic features of vermis morphology in bipolar disorder. Bipolar Disord. 2009;11:753–758. doi: 10.1111/j.1399-5618.2009.00745.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Rimol LM, Hartberg CB, Nesvag R, Fennema-Notestine C, Hagler DJ, Jr, Pung CJ, et al. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol Psychiatry. 2010;68:41–50. doi: 10.1016/j.biopsych.2010.03.036. [DOI] [PubMed] [Google Scholar]
  • 34.Baldacara L, Nery-Fernandes F, Rocha M, Quarantini LC, Rocha GG, Guimaraes JL, et al. Is cerebellar volume related to bipolar disorder? J Affect Disord. 2011;135:305–309. doi: 10.1016/j.jad.2011.06.059. [DOI] [PubMed] [Google Scholar]
  • 35.Kim D, Cho HB, Dager SR, Yurgelun-Todd DA, Yoon S, Lee JH, et al. Posterior cerebellar vermal deficits in bipolar disorder. J Affect Disord. 2013;150:499–506. doi: 10.1016/j.jad.2013.04.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Eker C, Simsek F, Yilmazer EE, Kitis O, Cinar C, Eker OD, et al. Brain regions associated with risk and resistance for bipolar I disorder: a voxel-based MRI study of patients with bipolar disorder and their healthy siblings. Bipolar Disord. 2014;16:249–261. doi: 10.1111/bdi.12181. [DOI] [PubMed] [Google Scholar]
  • 37.McCarthy MJ, Liang S, Spadoni AD, Kelsoe JR, Simmons AN. Whole brain expression of bipolar disorder associated genes: structural and genetic analyses. PLoS One. 2014;9:e100204. doi: 10.1371/journal.pone.0100204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Laidi C, d’Albis MA, Wessa M, Linke J, Phillips ML, Delavest M, et al. Cerebellar volume in schizophrenia and bipolar I disorder with and without psychotic features. Acta Psychiatr Scand. 2015;131:223–233. doi: 10.1111/acps.12363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Saricicek A, Yalin N, Hidiroglu C, Cavusoglu B, Tas C, Ceylan D, et al. Neuroanatomical correlates of genetic risk for bipolar disorder: A voxel-based morphometry study in bipolar type I patients and healthy first degree relatives. J Affect Disord. 2015;186:110–118. doi: 10.1016/j.jad.2015.06.055. [DOI] [PubMed] [Google Scholar]
  • 40.Loeber RT, Sherwood AR, Renshaw PF, Cohen BM, Yurgelun-Todd DA. Differences in cerebellar blood volume in schizophrenia and bipolar disorder. Schizophrenia Research. 1999;37:81–89. doi: 10.1016/s0920-9964(98)00137-6. [DOI] [PubMed] [Google Scholar]
  • 41.Ketter TA, Kimbrell TA, George MS, Dunn RT, Speer AM, Benson BE, et al. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry. 2001;49:97–109. doi: 10.1016/s0006-3223(00)00975-6. [DOI] [PubMed] [Google Scholar]
  • 42.Kruger S, Seminowicz D, Goldapple K, Kennedy SH, Mayberg HS. State and trait influences on mood regulation in bipolar disorder: blood flow differences with an acute mood challenge. Biol Psychiatry. 2003;54:1274–1283. doi: 10.1016/s0006-3223(03)00691-7. [DOI] [PubMed] [Google Scholar]
  • 43.Malhi GS, Lagopoulos J, Owen AM, Ivanovski B, Shnier R, Sachdev P. Reduced activation to implicit affect induction in euthymic bipolar patients: an fMRI study. J Affect Disord. 2007;97:109–122. doi: 10.1016/j.jad.2006.06.005. [DOI] [PubMed] [Google Scholar]
  • 44.Benson BE, Willis MW, Ketter TA, Speer A, Kimbrell TA, George MS, et al. Interregional cerebral metabolic associativity during a continuous performance task (Part II): differential alterations in bipolar and unipolar disorders. Psychiatry Res. 2008;164:30–47. doi: 10.1016/j.pscychresns.2007.12.016. [DOI] [PubMed] [Google Scholar]
  • 45.Kelly RM, Strick PL. Cerebellar loops with motor cortex and prefrontal cortex of a nonhuman primate. J Neurosci. 2003;23:8432–8444. doi: 10.1523/JNEUROSCI.23-23-08432.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Clower DM, West RA, Lynch JC, Strick PL. The inferior parietal lobule is the target of output from the superior colliculus, hippocampus, and cerebellum. J Neurosci. 2001;21:6283–6291. doi: 10.1523/JNEUROSCI.21-16-06283.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Anand BK, Malhotra CL, Singh B, Dua S. Cerebellar projections to limbic system. J Neurophysiol. 1959;22:451–457. doi: 10.1152/jn.1959.22.4.451. [DOI] [PubMed] [Google Scholar]
  • 48.Heath RG, Harper JW. Ascending projections of the cerebellar fastigial nucleus to the hippocampus, amygdala, and other temporal lobe sites: evoked potential and histological studies in monkeys and cats. Experimental neurology. 1974;45:268–287. doi: 10.1016/0014-4886(74)90118-6. [DOI] [PubMed] [Google Scholar]
  • 49.Snider RS, Maiti A. Cerebellar contributions to the Papez circuit. Journal of neuroscience research. 1976;2:133–146. doi: 10.1002/jnr.490020204. [DOI] [PubMed] [Google Scholar]
  • 50.Liu CH, Li F, Li SF, Wang YJ, Tie CL, Wu HY, et al. Abnormal baseline brain activity in bipolar depression: a resting state functional magnetic resonance imaging study. Psychiatry Res. 2012;203:175–179. doi: 10.1016/j.pscychresns.2012.02.007. [DOI] [PubMed] [Google Scholar]
  • 51.Liang MJ, Zhou Q, Yang KR, Yang XL, Fang J, Chen WL, Huang Z. Identify changes of brain regional homogeneity in bipolar disorder and unipolar depression using resting-state FMRI. PLoS One. 2013;8:e79999. doi: 10.1371/journal.pone.0079999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Wang Z, Meda SA, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA, et al. Large-Scale Fusion of Gray Matter and Resting-State Functional MRI Reveals Common and Distinct Biological Markers across the Psychosis Spectrum in the B-SNIP Cohort. Front Psychiatry. 2015;6:174. doi: 10.3389/fpsyt.2015.00174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Li M, Huang C, Deng W, Ma X, Han Y, Wang Q, et al. Contrasting and convergent patterns of amygdala connectivity in mania and depression: a resting-state study. J Affect Disord. 2015;173:53–58. doi: 10.1016/j.jad.2014.10.044. [DOI] [PubMed] [Google Scholar]
  • 54.Wang Y, Zhong S, Jia Y, Zhou Z, Wang B, Pan J, Huang L. Interhemispheric resting state functional connectivity abnormalities in unipolar depression and bipolar depression. Bipolar Disord. 2015;17:486–495. doi: 10.1111/bdi.12315. [DOI] [PubMed] [Google Scholar]
  • 55.Samudra N, Ivleva EI, Hubbard NA, Rypma B, Sweeney JA, Clementz BA, et al. Alterations in hippocampal connectivity across the psychosis dimension. Psychiatry Res. 2015;233:148–157. doi: 10.1016/j.pscychresns.2015.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Mamah D, Barch DM, Repovs G. Resting state functional connectivity of five neural networks in bipolar disorder and schizophrenia. J Affect Disord. 2013;150:601–609. doi: 10.1016/j.jad.2013.01.051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Du Y, Liu J, Sui J, He H, Pearlson GD, Calhoun VD. Exploring difference and overlap between schizophrenia, schizoaffective and bipolar disorders using resting-state brain functional networks. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual Conference. 2014;2014:1517–1520. doi: 10.1109/EMBC.2014.6943890. [DOI] [PubMed] [Google Scholar]
  • 58.Schmahmann JD, Pandya DN. The cerebrocerebellar system. Int Rev Neurobiol. 1997;41:31–60. doi: 10.1016/s0074-7742(08)60346-3. [DOI] [PubMed] [Google Scholar]
  • 59.Krienen FM, Buckner RL. Segregated fronto-cerebellar circuits revealed by intrinsic functional connectivity. Cereb Cortex. 2009;19:2485–2497. doi: 10.1093/cercor/bhp135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.D’Angelo E, Casali S. Seeking a unified framework for cerebellar function and dysfunction: from circuit operations to cognition. Front Neural Circuits. 2013;6:116. doi: 10.3389/fncir.2012.00116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Shinn AK, Baker JT, Lewandowski KE, Ongur D, Cohen BM. Aberrant cerebellar connectivity in motor and association networks in schizophrenia. Frontiers in human neuroscience. 2015;9:134. doi: 10.3389/fnhum.2015.00134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Yeo BT, Krienen FM, Sepulcre J, Sabuncu MR, Lashkari D, Hollinshead M, et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol. 2011;106:1125–1165. doi: 10.1152/jn.00338.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Buckner RL, Krienen FM, Castellanos A, Diaz JC, Yeo BT. The organization of the human cerebellum estimated by intrinsic functional connectivity. J Neurophysiol. 2011;106:2322–2345. doi: 10.1152/jn.00339.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Habas C, Kamdar N, Nguyen D, Prater K, Beckmann CF, Menon V, Greicius MD. Distinct cerebellar contributions to intrinsic connectivity networks. J Neurosci. 2009;29:8586–8594. doi: 10.1523/JNEUROSCI.1868-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Dobromyslin VI, Salat DH, Fortier CB, Leritz EC, Beckmann CF, Milberg WP, McGlinchey RE. Distinct functional networks within the cerebellum and their relation to cortical systems assessed with independent component analysis. Neuroimage. 2012;60:2073–2085. doi: 10.1016/j.neuroimage.2012.01.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Baker JT, Holmes AJ, Masters GA, Yeo BT, Krienen F, Buckner RL, Ongur D. Disruption of cortical association networks in schizophrenia and psychotic bipolar disorder. JAMA Psychiatry. 2014;71:109–118. doi: 10.1001/jamapsychiatry.2013.3469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P) New York, NY: Biometrics Research, New York State Psychiatric Institute; 2002. [Google Scholar]
  • 68.Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–435. doi: 10.1192/bjp.133.5.429. [DOI] [PubMed] [Google Scholar]
  • 69.Montgomery S, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry. 1979;134:382–389. doi: 10.1192/bjp.134.4.382. [DOI] [PubMed] [Google Scholar]
  • 70.Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 1987;13:261–276. doi: 10.1093/schbul/13.2.261. [DOI] [PubMed] [Google Scholar]
  • 71.Phillips ML, Travis MJ, Fagiolini A, Kupfer DJ. Medication effects in neuroimaging studies of bipolar disorder. Am J Psychiatry. 2008;165:313–320. doi: 10.1176/appi.ajp.2007.07071066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004;23(Suppl 1):S208–219. doi: 10.1016/j.neuroimage.2004.07.051. [DOI] [PubMed] [Google Scholar]
  • 73.Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002;17:825–841. doi: 10.1016/s1053-8119(02)91132-8. [DOI] [PubMed] [Google Scholar]
  • 74.Woolrich MW, Behrens TE, Beckmann CF, Jenkinson M, Smith SM. Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage. 2004;21:1732–1747. doi: 10.1016/j.neuroimage.2003.12.023. [DOI] [PubMed] [Google Scholar]
  • 75.Van Dijk KR, Sabuncu MR, Buckner RL. The influence of head motion on intrinsic functional connectivity MRI. Neuroimage. 2012;59:431–438. doi: 10.1016/j.neuroimage.2011.07.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Corbetta M, Patel G, Shulman GL. The reorienting system of the human brain: from environment to theory of mind. Neuron. 2008;58:306–324. doi: 10.1016/j.neuron.2008.04.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Fleck DE, Shear PK, Strakowski SM. Processing efficiency and sustained attention in bipolar disorder. Journal of the International Neuropsychological Society: JINS. 2005;11:49–57. doi: 10.1017/S1355617705050071. [DOI] [PubMed] [Google Scholar]
  • 78.Liu SK, Chiu CH, Chang CJ, Hwang TJ, Hwu HG, Chen WJ. Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers. Am J Psychiatry. 2002;159:975–982. doi: 10.1176/appi.ajp.159.6.975. [DOI] [PubMed] [Google Scholar]
  • 79.Wilder-Willis KE, Sax KW, Rosenberg HL, Fleck DE, Shear PK, Strakowski SM. Persistent attentional dysfunction in remitted bipolar disorder. Bipolar Disord. 2001;3:58–62. doi: 10.1034/j.1399-5618.2001.030202.x. [DOI] [PubMed] [Google Scholar]
  • 80.Sax KW, Strakowski SM, McElroy SL, Keck PE, Jr, West SA. Attention and formal thought disorder in mixed and pure mania. Biol Psychiatry. 1995;37:420–423. doi: 10.1016/0006-3223(95)00310-D. [DOI] [PubMed] [Google Scholar]
  • 81.Fleck DE, Eliassen JC, Durling M, Lamy M, Adler CM, DelBello MP, et al. Functional MRI of sustained attention in bipolar mania. Mol Psychiatry. 2012;17:325–336. doi: 10.1038/mp.2010.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Menon V, Uddin LQ. Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct. 2010;214:655–667. doi: 10.1007/s00429-010-0262-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Palaniyappan L, Simmonite M, White TP, Liddle EB, Liddle PF. Neural primacy of the salience processing system in schizophrenia. Neuron. 2013;79:814–828. doi: 10.1016/j.neuron.2013.06.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003;160:13–23. doi: 10.1176/appi.ajp.160.1.13. [DOI] [PubMed] [Google Scholar]
  • 85.Palaniyappan L, Mallikarjun P, Joseph V, White TP, Liddle PF. Reality distortion is related to the structure of the salience network in schizophrenia. Psychol Med. 2011;41:1701–1708. doi: 10.1017/S0033291710002205. [DOI] [PubMed] [Google Scholar]
  • 86.Neves Mde C, Duarte DG, Albuquerque MR, Nicolato R, Neves FS, Souza-Duran FL, et al. Neural correlates of hallucinations in bipolar disorder. Revista brasileira de psiquiatria. 2016;38:1–5. doi: 10.1590/1516-4446-2014-1640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Spreng RN, Stevens WD, Chamberlain JP, Gilmore AW, Schacter DL. Default network activity, coupled with the frontoparietal control network, supports goal-directed cognition. Neuroimage. 2010;53:303–317. doi: 10.1016/j.neuroimage.2010.06.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Negash A, Kebede D, Alem A, Melaku Z, Deyessa N, Shibire T, et al. Neurological soft signs in bipolar I disorder patients. J Affect Disord. 2004;80:221–230. doi: 10.1016/S0165-0327(03)00116-2. [DOI] [PubMed] [Google Scholar]
  • 89.Chrobak AA, Siwek GP, Siuda-Krzywicka K, Arciszewska A, Starowicz-Filip A, Siwek M, Dudek D. Neurological and cerebellar soft signs do not discriminate schizophrenia from bipolar disorder patients. Progress in neuro-psychopharmacology & biological psychiatry. 2016;64:96–101. doi: 10.1016/j.pnpbp.2015.07.009. [DOI] [PubMed] [Google Scholar]
  • 90.Keele SW, Ivry R. Does the cerebellum provide a common computation for diverse tasks? A timing hypothesis. Ann N Y Acad Sci. 1990;608:179–207. doi: 10.1111/j.1749-6632.1990.tb48897.x. discussion 207–111. [DOI] [PubMed] [Google Scholar]
  • 91.Schmahmann JD. Dysmetria of thought: clinical consequences of cerebellar dysfunction on cognition and affect. Trends Cogn Sci. 1998;2:362–371. doi: 10.1016/s1364-6613(98)01218-2. [DOI] [PubMed] [Google Scholar]
  • 92.Andreasen NC, Nopoulos P, O’Leary DS, Miller DD, Wassink T, Flaum M. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry. 1999;46:908–920. doi: 10.1016/s0006-3223(99)00152-3. [DOI] [PubMed] [Google Scholar]
  • 93.Andreasen NC. A unitary model of schizophrenia. Bleuler’s “Fragmented Phrene” as schizencephaly. Archives of General Psychiatry. 1999;56:781–787. doi: 10.1001/archpsyc.56.9.781. [DOI] [PubMed] [Google Scholar]
  • 94.Keshavan MS, Morris DW, Sweeney JA, Pearlson G, Thaker G, Seidman LJ, et al. A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale. Schizophr Res. 2011;133:250–254. doi: 10.1016/j.schres.2011.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Lewandowski KE, Cohen BM, Keshavan MS, Ongur D. Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses. Schizophr Res. 2011;133:212–217. doi: 10.1016/j.schres.2011.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009;373:234–239. doi: 10.1016/S0140-6736(09)60072-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Van Snellenberg JX, de Candia T. Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder. Arch Gen Psychiatry. 2009;66:748–755. doi: 10.1001/archgenpsychiatry.2009.64. [DOI] [PubMed] [Google Scholar]
  • 98.Moskvina V, Craddock N, Holmans P, Nikolov I, Pahwa JS, Green E, et al. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry. 2009;14:252–260. doi: 10.1038/mp.2008.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.International Schizophrenia Consortium. Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748–752. doi: 10.1038/nature08185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Williams HJ, Craddock N, Russo G, Hamshere ML, Moskvina V, Dwyer S, et al. Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. Human molecular genetics. 2011;20:387–391. doi: 10.1093/hmg/ddq471. [DOI] [PubMed] [Google Scholar]
  • 101.Yang SY, Huh IS, Baek JH, Cho EY, Choi MJ, Ryu S, et al. Association between ST8SIA2 and the Risk of Schizophrenia and Bipolar I Disorder across Diagnostic Boundaries. PLoS One. 2015;10:e0139413. doi: 10.1371/journal.pone.0139413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Curtis VA, van Os J, Murray RM. The Kraepelinian dichotomy: evidence from developmental and neuroimaging studies. J Neuropsychiatry Clin Neurosci. 2000;12:398–405. doi: 10.1176/jnp.12.3.398. [DOI] [PubMed] [Google Scholar]
  • 103.Ellison-Wright I, Bullmore E. Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr Res. 2010;117:1–12. doi: 10.1016/j.schres.2009.12.022. [DOI] [PubMed] [Google Scholar]
  • 104.Frangou S. A systems neuroscience perspective of schizophrenia and bipolar disorder. Schizophr Bull. 2014;40:523–531. doi: 10.1093/schbul/sbu017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Craddock N, Owen MJ. Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages. World psychiatry: official journal of the World Psychiatric Association. 2007;6:84–91. [PMC free article] [PubMed] [Google Scholar]
  • 106.Jaatinen P, Rintala J. Mechanisms of ethanol-induced degeneration in the developing, mature, and aging cerebellum. Cerebellum. 2008;7:332–347. doi: 10.1007/s12311-008-0034-z. [DOI] [PubMed] [Google Scholar]
  • 107.Ma YL, Weston SE, Whalley BJ, Stephens GJ. The phytocannabinoid Delta(9)-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum. British journal of pharmacology. 2008;154:204–215. doi: 10.1038/bjp.2008.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Rapp C, Bugra H, Riecher-Rossler A, Tamagni C, Borgwardt S. Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies. Curr Pharm Des. 2012;18:5070–5080. doi: 10.2174/138161212802884861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Batalla A, Bhattacharyya S, Yucel M, Fusar-Poli P, Crippa JA, Nogue S, et al. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS One. 2013;8:e55821. doi: 10.1371/journal.pone.0055821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR. What does the PANSS mean? Schizophr Res. 2005;79:231–238. doi: 10.1016/j.schres.2005.04.008. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

supplement

RESOURCES